|
1.
|
Riley V: Mouse mammary tumors: alteration
of incidence as apparent function of stress. Science. 189:465–467.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Antoni MH, Lutgendorf SK, Cole SW, Dhabhar
FS, Sephton SE, McDonald PG, Stefanek M and Sood AK: The influence
of bio-behavioural factors on tumour biology: pathways and
mechanisms. Nat Rev Cancer. 6:240–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Massie MJ: Prevalence of depression in
patients with Cancer. J Natl Cancer Inst Monogr. 32:57–71. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Carlson LE, Angen M, Cullum J, Goodey E,
Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J,
Simpson JS, Speca M, Tillotson L and Bultz BD: High levels of
untreated distress and fatigue in cancer patients. Br J Cancer.
90:2297–2304. 2004.PubMed/NCBI
|
|
5.
|
Garssen B: Psychological factors and
cancer development: evidence after 30 years of research. Clin
Psychol Rev. 24:315–338. 2004.PubMed/NCBI
|
|
6.
|
Chida Y, Hamer M, Wardle J and Steptoe A:
Do stress-related psychosocial factors contribute to cancer
incidence and survival? Nat Clin Pract Oncol. 5:466–475. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Thaker PH, Han LY, Kamat AA, Arevalo JM,
Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori
M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN,
Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM,
Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW and Sood AK:
Chronic stress promotes tumor growth and angiogenesis in a mouse
model of ovarian carcinoma. Nat Med. 12:939–944. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Sood AK, Bhatty R, Kamat AA, Landen CN,
Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S and Cole SW:
Stress hormone-mediated invasion of ovarian cancer cells. Clin
Cancer Res. 12:369–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
McEwen BS: Mood disorders and allostatic
load. Biol Psychiatry. 54:200–207. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Vanitallie TB: Stress: a risk factor for
serious illness. Metabolism. 51:40–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Fu L and Lee CC: The circadian clock:
pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–361. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Sephton S and Spiegel D: Circadian
disruption in cancer: a neuroendocrine-immune pathway from stress
to disease? Brain Behav Immun. 17:321–328. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Glaser R and Glaser JK: Stress-induced
immune dysfunction: implications for health. Nat Rev Immunol.
5:243–251. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Reiche EM, Nunes SO and Morimoto HK:
Stress, depression, the immune system and cancer. Lancet Oncol.
5:617–625. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Padgett DA and Glaser R: How stress
influences the immune response. Trends Immunol. 24:444–448. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Segerstrom SC and Miller GE: Psychological
stress and the human immune system: A meta-analytic study of 30
years of inquiry. Psychol Bull. 130:601–630. 2004.PubMed/NCBI
|
|
17.
|
Lutgendorf SK, Cole S, Costanzo E, Bradley
S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M and Sood
AK: Stress-related mediators stimulate vascular endothelial growth
factor secretion by two ovarian cancer cell lines. Clin Cancer Res.
9:4514–4521. 2003.PubMed/NCBI
|
|
18.
|
Hall RA: Beta-adrenergic receptors and
their interacting proteins. Semin Cell Dev Biol. 15:281–288. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Dorsam RT and Gutkind JS:
G-protein-coupled receptors and cancer. Nat Rev Cancer. 7:79–94.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
O’Connor KL and Mercurio AM: Protein
kinase A regulates Rac and is required for the growth
factor-stimulated migration of carcinoma cells. J Biol Chem.
276:47895–47900. 2001.PubMed/NCBI
|
|
21.
|
Rangarajan S, Enserink JM, Kuiperij HB,
Rooij J, Price LS, Schwede F and Bos JL: Cyclic AMP induces
integrin-mediated cell adhesion through Epac and Rap1 upon
stimulation of the β2-adrenergic receptor. J Cell Biol.
160:487–493. 2003.PubMed/NCBI
|
|
22.
|
Schmitt JM and Stork JS: β2-Adrenergic
receptor activates extracellular signal-regulated kinases (ERKs)
via the small G protein Rap1 and the serine/threonine kinase B-Raf.
J Biol Chem. 275:25342–25350. 2000.
|
|
23.
|
Shenoy SK, Drake MT, Nelson CD, Houtz DA,
Kunhong X, Madabushi S, Reiter E, Premont RT, Lichtarge O and
Lefkowitz RJ: β-arrestin-dependent, G protein-independent ERK1/2
activation by the β2-adrenergic receptor. J Biol Chem.
281:1261–1273. 2006.
|
|
24.
|
Tsurutani J, Castillo SS, Brognard J,
Granville CA, Chunyu Z, Gills JJ, Sayyah J and Dennis PA: Tobacco
components stimulate Akt-dependent proliferation and
NF-κB-dependent survival in lung cancer cells. Carcinogenesis.
26:1182–1195. 2005.PubMed/NCBI
|
|
25.
|
Maudsley S, Pierce KL, Zamah AM, Miller
WE, Ahn S, Daaka Y, Lefkowitz RJ and Luttrell LM: The β2-Adrenergic
receptor mediates extracellular signal-regulated kinase activation
via assembly of a multi-receptor complex with the epidermal growth
factor receptor. J Biol Chem. 275:9560–9572. 2000.
|
|
26.
|
Drube S, Stirnweiss J, Valkova C and
Liebmann C: Ligand-independent and EGF receptor-supported
transactivation: lessons from beta2-adrenergic receptor signalling.
Cell Signal. 18:1633–1646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Herr I, Ucur E, Herzer K, Okouoyo S,
Ridder R, Krammer PH, Doeberitz MK and Debatin KM: Glucocorticoid
cotreatment induces apoptosis resistance toward cancer therapy in
carcinomas. Cancer Res. 63:3112–3120. 2003.PubMed/NCBI
|
|
28.
|
Herr I and Pfitzenmaier J: Glucocorticoid
use in prostate cancer and other solid tumours: implications for
effectiveness of cytotoxic treatment and metastases. Lancet Oncol.
7:425–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
NØrgaard P and Poulsen HS: Glucocorticoid
receptors in human malignancies: a review. Ann Oncol. 2:541–557.
1991.PubMed/NCBI
|
|
30.
|
Petrella A, Ercolino SF, Festa M,
Gentilella A, Tosco A, Conzen SD and Parente L: Dexamethasone
inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL
induction. Eur J Cancer. 42:3287–3293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Runnebaum IB and Brüning A:
Glucocorticoids inhibit cell death in ovarian cancer and
up-regulate caspase inhibitor cIAP2. Clin Cancer Res. 11:6325–6332.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Hadcock JR, Wang HY and Malbon CC:
Agonist-induced destabilization of beta-adrenergic receptor mRNA.
Attenuation of glucocorticoid-induced up-regulation of
beta-adrenergic receptors. J Biol Chem. 264:19928–19933.
1989.PubMed/NCBI
|
|
33.
|
Landen CN Jr, Lin YG, Armaiz Pena GN, Das
PD, Arevalo JM, Kamat AA, Han LY, Jennings NB, Spannuth WA, Thaker
PH, Lutgendorf SK, Savary CA, Sanguino AM, Lopez-Berestein G, Cole
SW and Sood AK: Neuroendocrine modulation of signal transducer and
activator of transcription-3 in ovarian cancer. Cancer Res.
67:10389–10396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Liping Z, Cui R, Xiaodong CH and Jie D:
Antiapoptotic effect of serum and glucocorticoid-inducible protein
kinase is mediated by novel mechanism activating IκB kinase. Cancer
Res. 65:457–464. 2005.PubMed/NCBI
|
|
35.
|
Wei W, Min Z, Brickley DR, Pew T and
Conzen SD: Glucocorticoid receptor activation signals through
forkhead transcription factor 3a in breast cancer cells. Mol
Endocrinol. 20:2304–2314. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Goodspeed MC and Lee CC: Tumor suppression
and circadian function. J Biol Rhythms. 22:291–298. 2007.
View Article : Google Scholar
|
|
37.
|
Hastings M, O’Neill JS and Maywood ES:
Circadian clocks: regulators of endocrine and metabolic rhythms. J
Endocrinol. 195:187–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ
and Chang JG: Deregulated expression of the PER1, -PER2 and PER3
genes in breast cancers. Carcinogenesis. 26:1241–1246. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Rasmuson T, Ljungberg B, Grankvist K,
Jacobsen J and Olsson T: Increased serum cortisol levels are
associated with high tumour grade in patients with renal cell
carcinoma. Acta Oncol. 40:83–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Dickmeis T: Glucocorticoids and the
circadian clock. J Endocrinol. 200:3–22. 2009. View Article : Google Scholar
|
|
41.
|
Andersen BL, Farrar WB, Golden-Kreutz DM,
Glaser R, Emery CF, Crespin TR, Shapiro CL and Carson WE:
Psychological, behavioral and immune changes after a psychological
intervention: a clinical trial. J Clin Oncol. 22:3570–3580. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Jacobsen PB and Jim HS: Psychosocial
interventions for anxiety and depression in adult cancer patients:
achievements and challenges. CA Cancer J Clin. 58:214–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Küchler T, Bestmann B, Rappat S,
Henne-Bruns D and Wood-Dauphinee S: Impact of psychotherapeutic
support for patients with gastrointestinal cancer undergoing
surgery: 10-year survival results of a randomized trial. J Clin
Oncol. 25:2702–2708. 2007.PubMed/NCBI
|
|
44.
|
Steingart AB and Cotterchio M: Do
antidepressants cause, promote, or inhibit cancers? J Clin
Epidemiol. 48:1407–1412. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Brandes LJ: Hormetic effects of hormones,
antihormones and antidepressants on cancer cell growth in culture:
in vivo correlates. Crit Rev Toxicol. 35:587–592. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Algazi M, Plu-Bureau G, Flahault A, Dondon
MG and Le MG: Is beta-blocker treatment associated with a decrease
in the risk of cancer? Drug Des Discov. 3:653–661. 2006. View Article : Google Scholar
|
|
47.
|
Benish M, Bartal I, Goldfarb Y, Levi1 B,
Avraham1 R, Raz A and Ben-Eliyahu S: Perioperative use of
β-blockers and COX-2 inhibitors may improve immune competence and
reduce the risk of tumor metastasis. Ann Surg Oncol. 15:2042–2052.
2008.
|
|
48.
|
Boesen EH and Johansen C: Impact of
psychotherapy on cancer survival: time to move on? Curr Opin Oncol.
20:372–377. 2008. View Article : Google Scholar : PubMed/NCBI
|
